J K Pharmachem Ltd
J K Pharmachem Ltd Live Price Chart
J K Pharmachem Ltd Technicals
| 20 Day | ₹ 0.000 |
| 50 Day | ₹ 0.000 |
| 100 Day | ₹ 0.000 |
| 200 Day | ₹ 0.000 |
| 20 Day | ₹ 0.000 |
| 50 Day | ₹ 0.000 |
| 100 Day | ₹ 0.000 |
| 200 Day | ₹ 0.000 |
J K Pharmachem Ltd Performance
| Previous Close | ₹ |
| High | ₹ |
| Volume | |
| 52W Range | ₹ - ₹ |
| Open | ₹ |
| Low | ₹ |
| Market Cap | ₹ 11 Cr |
J K Pharmachem Ltd Fundamentals
| ROCE | 0.000 |
| P/E Ratio | -1.370 |
| P/B Ratio | 0.000 |
| Industry P/E | 0.000 |
| Debt to Equity | 39.451 |
| ROE | 0.000 |
| EPS | -1.310 |
| Dividend Yield | 0.000 |
| Book Value | -5.969 |
| Face Value | 10.000 |
J K Pharmachem Ltd Financials
| No data found |
J K Pharmachem Ltd Shareholding Pattern
| Promoter Holdings | 0.000 % |
| FIIs | 0.000 % |
| DIIs | 0.000 % |
| MutualFund | 0.000 % |
| Retail | 0.000 % |
| Others - | 0.000 % |
About J K Pharmachem Ltd
History of J K Pharmachem Ltd
Jointly promoted by J K Industries and TIDCO, J K Pharmachem manufactures drugs and pharmaceuticals. It entered the capital market in Oct.'94 to part-finance the setting up of a plant to manufacture 1250 MMU P.a of pencillin-G, based on a microbial strain from the technical collaborators -- IGC (Cyprus), Cyprus -- a wholly-owned subsidiary of ICN Galenika. Commercial production at this plant commenced in Oct.'95. The company has a tie-up with ICN Galenika, part of the ICN Pharmaceuticals group (one of the pioneering manufacturers of pencillin-G), to set up a 1250-mmu capacity plant. It has already produced international standard penicillin with Indian raw materials, at its collaborator's plant which is among the best in the world. In addition, J K Pharmachem had set-up its own R&D activity well in advance for future development in the field of bio-technology. A pilot plant is also being established for this purpose at Cuddalore, Tamilnadu. The company also plans to diversify into speciality fermentation products. It has also started production of Penicillin-V and is the only one in India to produce this bulk active. During 1999-2000, the company started the production of Penicillin V and is the only producer of this important bulk active in India. The accumulated losses of the company having exceeded 50% of the peak networth of the company in the immediately preceding four financial years, the company took the necessary steps of SICA, 1985. The company developed ...
